pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    ABBVCLS-628
    Polycystic Kidney Disease Calico Life Sciences LLC
  • Phase 1
    ABD-147
    Neuroendocrine Carcinoma Abdera Therapeutics Inc
  • Preclinical
    ABG-023
    Hyperinsulinemia AmideBio LLC
  • Phase 2
← prev
page 49 of 271
next →
Pain89
Neurology1
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
  • Phase 1
    ABI-1179
    Genital Herpes$GILD GILEAD SCIENCES, INC.
  • Preclinical
    ABI-171
    Idiopathic Pulmonary Fibrosis Avanti Biosciences Inc
  • ABIGALE LO
    ABIGALE LO (ESTRADIOL AND NORETHINDRONE ACETATE)
    no indication XIROMED
  • ABILIFY MAINTENA KIT
    ABILIFY MAINTENA KIT (ARIPIPRAZOLE)
    no indication Otsuka Pharmaceutical Co Ltd
  • Preclinical
    ABN-501
    Solid Tumor Abion Inc
  • Phase 2
    ABO-101
    Primary Hyperoxaluria Type I Chiesi Farmaceutici SpA
  • Preclinical
    ABO-503
    Retinal Degeneration$ABEO ABEONA THERAPEUTICS INC.
  • Preclinical
    ABO-504
    Juvenile Macular Degeneration (Stargardt Disease)$ABEO ABEONA THERAPEUTICS INC.
  • Preclinical
    ABO-505
    Optic Neuropathy$ABEO ABEONA THERAPEUTICS INC.
  • Phase 2
    ABP-745
    Gouty Arthritis (Gout) Atom Therapeutics Co Ltd
  • Phase 1
    ABS-0871
    Charcot-Marie-Tooth Disease Type II Actio Biosciences Inc
  • Phase 2
    ABS-201
    Androgenic Alopecia Almirall SA
  • Phase 1
    ABSK-112
    Non-Small Cell Lung Cancer Abbisko Therapeutics Co Ltd
  • Phase 1
    ABSK-121
    Bile Duct Cancer (Cholangiocarcinoma) Abbisko Therapeutics Co Ltd
  • Phase 2
    ABSK-141
    Solid Tumor Abbisko Therapeutics Co Ltd
  • Phase 1
    ABX-1100
    Pompe Disease Aro Biotherapeutics Co
  • Preclinical
    ABX-919
    Atopic Dermatitis (Atopic Eczema) Abrax Japan
  • Phase 1
    AC-0676
    Diffuse Large B-Cell Lymphoma Accutar Biotechnology Inc
  • Phase 1
    AC-0699
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Accutar Biotechnology Inc
  • Preclinical
    AC-1
    Traumatic Brain Injury AivoCode LLP
  • ACAMPROSATE CALCIUM
    ACAMPROSATE CALCIUM
    no indication Appco Pharma LLC
  • Preclinical
    ACAR-198
    Autoimmune Disorders AbelZeta Inc
  • ACCRUFER
    ACCRUFER (FERRIC MALTOL)
    no indication Shield TX (UK) Ltd
  • Phase 2
    ACD-440
    Neuropathic Pain (Neuralgia) AlzeCure Pharma AB
  • Phase 2
    ACDN-01
    Juvenile Macular Degeneration (Stargardt Disease) Ascidian Therapeutics Inc
  • Phase 1
    ACE-1334
    Systemic Sclerosis (Scleroderma)$MRK Merck & Co., Inc.